NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Jun 16, 2025 |
| Due Date: | Jul 9, 2025 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Jun 16, 2025 11:07 am EDT
- Original Response Date: Jul 09, 2025 05:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Jul 24, 2025
- Initiative:
- Original Set Aside:
- Product Service Code:
- NAICS Code:
-
Place of Performance:
This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR).
The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR.
The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.
Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.
In this study, we propose to design a better RH5-based vaccine by a structure-based approach. Independently, and not as an agent of the Government, the Subcontractor shall furnish the necessary management oversight and personnel for the performance of laboratory animal support services. The Subcontractor will be responsible for providing husbandry and technical support services required for the proper care, use and humane treatment of laboratory animals in their respective contract facility.
Leidos Biomedical Research, Inc. Point of Contact for a copy of Solicitation/RFP No: S25-104:
Cody Wenner at cody.wenner@nih.gov
For information concerning other opportunities with the FNLCR, please refer to:
https://frederick.cancer.gov/workwithus/solicitations
- OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
- Bethesda , MD 20892
- USA
- Cody Wenner
- cody.wenner@nih.gov
- Jun 16, 2025 11:07 am EDTSpecial Notice (Original)
See Also
Follow 66--PITOT-STATIC TUBE Active Contract Opportunity Notice ID SPE4A526T426D Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Due by 9/23/2026
Follow TRANSMITTER,PRESSUR Active Contract Opportunity Notice ID N0010426QND87 Related Notice Department/Ind. Agency DEPT
DEPT OF DEFENSE
Due by 10/16/2026
Follow Purchase of Two LightLab 3 LE High Sensitivity Cannabis Analyzers Active Contract
HOMELAND SECURITY, DEPARTMENT OF
Due by 9/23/2026
Follow 66--CONTROL-DISPLAY UNI, IN REPAIR/MODIFICATION OF Active Contract Opportunity Notice ID N0038326QNB22 Related
DEPT OF DEFENSE
Due by 10/26/2026